ZMYM2 and leukemia: Donor lymphocyte infusions have been shown to offer potential in eliminating MRD by mediating graft-versus-leukemia activity in a previous case of ZMYM2-FGFR1 MPN [5] and which may have been achieved in this case by the ongoing chronic GVHD.